753 related articles for article (PubMed ID: 32576970)
1. LNC942 promoting METTL14-mediated m
Sun T; Wu Z; Wang X; Wang Y; Hu X; Qin W; Lu S; Xu D; Wu Y; Chen Q; Ding X; Guo H; Li Y; Wang Y; Fu B; Yao W; Wei M; Wu H
Oncogene; 2020 Jul; 39(31):5358-5372. PubMed ID: 32576970
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of METTL14 mediates the elevation of PERP mRNA N
Wang M; Liu J; Zhao Y; He R; Xu X; Guo X; Li X; Xu S; Miao J; Guo J; Zhang H; Gong J; Zhu F; Tian R; Shi C; Peng F; Feng Y; Yu S; Xie Y; Jiang J; Li M; Wei W; He C; Qin R
Mol Cancer; 2020 Aug; 19(1):130. PubMed ID: 32843065
[TBL] [Abstract][Full Text] [Related]
3. LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c-Myc mRNA stability.
Zhu Y; Zhou B; Hu X; Ying S; Zhou Q; Xu W; Feng L; Hou T; Wang X; Zhu L; Jin H
Clin Transl Med; 2022 Jan; 12(1):e703. PubMed ID: 35073459
[TBL] [Abstract][Full Text] [Related]
4. Targeting histone deacetylase suppresses tumor growth through eliciting METTL14-modified m
Zhuang A; Gu X; Ge T; Wang S; Ge S; Chai P; Jia R; Fan X
Cancer Commun (Lond); 2023 Nov; 43(11):1185-1206. PubMed ID: 37466203
[TBL] [Abstract][Full Text] [Related]
5. LncRNA UCA1 promotes SOX12 expression in breast cancer by regulating m
Zhao C; Ling X; Xia Y; Yan B; Guan Q
Cancer Gene Ther; 2022 Jul; 29(7):1043-1055. PubMed ID: 35022519
[TBL] [Abstract][Full Text] [Related]
6. Functions, mechanisms, and therapeutic implications of METTL14 in human cancer.
Guan Q; Lin H; Miao L; Guo H; Chen Y; Zhuo Z; He J
J Hematol Oncol; 2022 Feb; 15(1):13. PubMed ID: 35115038
[TBL] [Abstract][Full Text] [Related]
7. METTL14 promotes the migration and invasion of breast cancer cells by modulating N6‑methyladenosine and hsa‑miR‑146a‑5p expression.
Yi D; Wang R; Shi X; Xu L; Yilihamu Y; Sang J
Oncol Rep; 2020 May; 43(5):1375-1386. PubMed ID: 32323801
[TBL] [Abstract][Full Text] [Related]
8. m
Liu P; Fan B; Othmane B; Hu J; Li H; Cui Y; Ou Z; Chen J; Zu X
Theranostics; 2022; 12(14):6291-6307. PubMed ID: 36168624
[TBL] [Abstract][Full Text] [Related]
9. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
[TBL] [Abstract][Full Text] [Related]
10. METTL14 promotes tumorigenesis by regulating lncRNA OIP5-AS1/miR-98/ADAMTS8 signaling in papillary thyroid cancer.
Zhang X; Li D; Jia C; Cai H; Lv Z; Wu B
Cell Death Dis; 2021 Jun; 12(6):617. PubMed ID: 34131102
[TBL] [Abstract][Full Text] [Related]
11. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.
Yang X; Zhang S; He C; Xue P; Zhang L; He Z; Zang L; Feng B; Sun J; Zheng M
Mol Cancer; 2020 Feb; 19(1):46. PubMed ID: 32111213
[TBL] [Abstract][Full Text] [Related]
12. Methyltransferase-like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1.
Liu T; Wang H; Fu Z; Wang Z; Wang J; Gan X; Wang A; Wang L
Cancer Sci; 2022 Feb; 113(2):446-458. PubMed ID: 34813676
[TBL] [Abstract][Full Text] [Related]
13. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q
Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681
[TBL] [Abstract][Full Text] [Related]
14. Correction to: LNC942 promoting METTL14-mediated m 6 A methylation in breast cancer cell proliferation and progression.
Sun T; Wu Z; Wang X; Wang Y; Hu X; Qin W; Lu S; Xu D; Wu Y; Chen Q; Ding X; Guo H; Li Y; Wang Y; Fu B; Yao W; Wei M; Wu H
Oncogene; 2022 Mar; 41(11):1677. PubMed ID: 35169255
[No Abstract] [Full Text] [Related]
15. LncRNA UCA1 Promotes the Progression of AML by Upregulating the Expression of CXCR4 and CYP1B1 by Affecting the Stability of METTL14.
Li J; Li Z; Bai X; Chen X; Wang M; Wu Y; Wu H
J Oncol; 2022; 2022():2756986. PubMed ID: 35178087
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA ZFAS1 promoting small nucleolar RNA-mediated 2'-O-methylation via NOP58 recruitment in colorectal cancer.
Wu H; Qin W; Lu S; Wang X; Zhang J; Sun T; Hu X; Li Y; Chen Q; Wang Y; Zhao H; Piao H; Zhang R; Wei M
Mol Cancer; 2020 May; 19(1):95. PubMed ID: 32443980
[TBL] [Abstract][Full Text] [Related]
17. Changes of N6-methyladenosine modulators promote breast cancer progression.
Wu L; Wu D; Ning J; Liu W; Zhang D
BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473
[TBL] [Abstract][Full Text] [Related]
18. Downregulated METTL14 accumulates BPTF that reinforces super-enhancers and distal lung metastasis via glycolytic reprogramming in renal cell carcinoma.
Zhang C; Chen L; Liu Y; Huang J; Liu A; Xu Y; Shen Y; He H; Xu D
Theranostics; 2021; 11(8):3676-3693. PubMed ID: 33664855
[No Abstract] [Full Text] [Related]
19. N6-methyladenosine methyltransferase plays a role in hypoxic preconditioning partially through the interaction with lncRNA H19.
Su Y; Xu R; Zhang R; Qu Y; Zuo W; Ji Z; Geng H; Pan M; Ma G
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(12):1306-1315. PubMed ID: 33197240
[TBL] [Abstract][Full Text] [Related]
20. N6-methyladenine- induced LINC00667 promoted breast cancer progression through m6A/KIAA1429 positive feedback loop.
Ren S; Zhang Y; Yang X; Li X; Zheng Y; Liu Y; Zhang X
Bioengineered; 2022 May; 13(5):13462-13473. PubMed ID: 36700472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
